A clinical relevance between the expression of TNFAIP6/PLK1 and overall survival rate (OS) was observed in patients with lung cancer (Fig. S1C), LUAD (Fig. 1B), and LUSQ (Fig. S1D) using a Kaplan-Meier (KM) plot database 22. This evidence concerns the gene TNFAIP6 and lung carcinoma.